Re: Urinary Tract Infections and IC

[Guest guest]

Hi,

I know a few of you suffer from IC or urinary tract infections so I thought

I would pass along some information regarding D-Mannose, a supplement Dr.

Leu has prescribed for me for UTIs and IC pain. It has worked very well for

me almost immediately. Dr. Mercola even recommends and sells D-Mannose.

Kenda

D-MANNOSE & URINARY TRACT INFECTIONS (Including SCI)

Abstracted and Edited from a Report Submitted to Progressive Laboratories by

Blue, M.D., Urologist (Norman, OK)

See D-Mannose & UTI overview article

INTRODUCTION:

D-Mannose is a natural occurring simple sugar that appears to be a safe,

practical alternative for the treatment of urinary tract infections (UTI¹s).

D-Mannose is absorbed eight times slower than glucose, and when ingested, is

not converted to glycogen or stored in the liver, but rather goes directly

to the blood stream from the upper GI tract. Hence, D-Mannose is mostly

filtered through the kidneys and routed to the bladder.

The bladder lining is comprised of polysaccharide molecules. Finger-like

projections on the cell surface of E. coli bacteria adhere to these

molecules, initiating an infection. In the presence of D-Mannose, E. coli

preferentially attach to D-Mannose molecules forming a complex which is

expelled with the next voiding.

D-Mannose probably works 80-90% of the time because the bacteria disabled by

Mannose causes 80-90% of UTI¹s. Whereas antibiotic treatment radically

changes GI bacterial populations required for good health, potentially

causing fungal or gastrointestinal infections, D-Mannose removes ³bad²

bacteria by attachment and voiding.

SUBJECTS:

Study subjects were Dr. Blue¹s long-term patients, who had a history

of reoccurring UTI¹s. Subjects included 42 females (12-83 years old) and 18

males (25-71 years old). After urine culture to determine specific bacterial

cause, if any, subjects were started on a D-Mannose daily regimen.

RESULTS:

Of the 42 female subjects, 24 were confirmed by culture to have a UTI. In 19

cases (~80%), E. coli was the diagnosed cause, in four, Klebsiella, and in

one, mixed bacteria.

In the confirmed culture group, two scoops of D-Mannose daily were given for

one week. Of the 12 (50%) who returned for follow-up cultures, eight were

negative. Patients indicated that the symptoms had disappeared.

Statistically, 17 of the 24 (71%) females in the confirmed-culture,

D-mannose-treated group reported symptom improvement. Although three of the

24 (12.5%) were unable to be contacted, they did not return for additional

treatment. Only four of 24 (17%) reported no symptom improvement after

D-Mannose treatment.

Those females who were not confirmed by culture to have bacterial UTI but

had UTI-associated symptoms were classified into a painful-bladder-syndrome

(PBS) group. Of the 18 PBS females who were treated daily with two scoops of

D-Mannose, 17 (94%) reported symptom improvement, the lone exception being a

subject unable to be contacted, but also not returning for treatment. Eighty

percent became totally symptom free.

Of the 18 male subjects, 10 were confirmed by culture to have a UTI. Seven

had neurogenic bladders from spinal cord injuries, three of whom were on

intermittent catheterization and four had indwelling supra-pubic tubes.

Two men had been incapacitated with recurrent sepsis, retention, and

obstructive uropathy. Both men underwent insertion of supra pubic tubes.

Once released from the hospital, both were placed on a D-Mannose daily

regimen. Improvement was suggested by their ability to avoid additional

hospitalization.

In the group diagnosed with E. coli-related UTI and treated with D-Mannose,

significant improvement was reported. Due to the composition of the male

group, few responded as dramatically as females.

FINDINGS:

Consistent with existing literature, about 50% of those reporting UTI

symptoms were actually confirmed by culture to possess bacterial infection.

The therapeutic use of D-Mannose on acute UTI¹s in this study was effective

in eliminating or ameliorating symptoms.

In addition, 80% of the painful-bladder-syndrome group became symptom free

using D-Mannose.

Over the six-month study, three females with different issues showed

especially noteworthy responses to D-Mannose. The first was a 50-year old

female with neurogenic bladder and incontinence suffering from a monthly

UTI. Endoscopically, her bladder revealed numerous areas compatible with

recurrent UTI¹s. After three months of D-Mannose, her urine was sterile, and

her bladder mucosa returned to normal. The second woman complained about

bladder pain for which she had received numerous, unsuccessful therapies.

After one week of D-Mannose, her pain ceased. The third woman presented an

E. coli infection and pronounced structural findings in her bladder called

Cystitis Cystica, all of which disappeared after three months on D-Mannose.

In conclusion, D-Mannose appears to effectively treat simple, uncomplicated

UTI's.

[Guest guest]

I know women who swear by medical grade aloe for urinary tract infections.

Lynda

At 02:28 PM 12/31/2005, you wrote:

>Hi,

>

>I know a few of you suffer from IC or urinary tract infections so I thought

>I would pass along some information regarding D-Mannose, a supplement Dr.

>Leu has prescribed for me for UTIs and IC pain. It has worked very well for

>me almost immediately. Dr. Mercola even recommends and sells D-Mannose.

>

>Kenda

>

>

>D-MANNOSE & URINARY TRACT INFECTIONS (Including SCI)

>Abstracted and Edited from a Report Submitted to Progressive Laboratories by

> Blue, M.D., Urologist (Norman, OK)

>

>

>

>See D-Mannose & UTI overview article

>

>INTRODUCTION:

>

>D-Mannose is a natural occurring simple sugar that appears to be a safe,

>practical alternative for the treatment of urinary tract infections (UTI¹s).

>D-Mannose is absorbed eight times slower than glucose, and when ingested, is

>not converted to glycogen or stored in the liver, but rather goes directly

>to the blood stream from the upper GI tract. Hence, D-Mannose is mostly

>filtered through the kidneys and routed to the bladder.

>

>The bladder lining is comprised of polysaccharide molecules. Finger-like

>projections on the cell surface of E. coli bacteria adhere to these

>molecules, initiating an infection. In the presence of D-Mannose, E. coli

>preferentially attach to D-Mannose molecules forming a complex which is

>expelled with the next voiding.

>

>D-Mannose probably works 80-90% of the time because the bacteria disabled by

>Mannose causes 80-90% of UTI¹s. Whereas antibiotic treatment radically

>changes GI bacterial populations required for good health, potentially

>causing fungal or gastrointestinal infections, D-Mannose removes ³bad²

>bacteria by attachment and voiding.

>

>SUBJECTS:

>

>Study subjects were Dr. Blue¹s long-term patients, who had a history

>of reoccurring UTI¹s. Subjects included 42 females (12-83 years old) and 18

>males (25-71 years old). After urine culture to determine specific bacterial

>cause, if any, subjects were started on a D-Mannose daily regimen.

>

>RESULTS:

>

>Of the 42 female subjects, 24 were confirmed by culture to have a UTI. In 19

>cases (~80%), E. coli was the diagnosed cause, in four, Klebsiella, and in

>one, mixed bacteria.

>

>In the confirmed culture group, two scoops of D-Mannose daily were given for

>one week. Of the 12 (50%) who returned for follow-up cultures, eight were

>negative. Patients indicated that the symptoms had disappeared.

>

>Statistically, 17 of the 24 (71%) females in the confirmed-culture,

>D-mannose-treated group reported symptom improvement. Although three of the

>24 (12.5%) were unable to be contacted, they did not return for additional

>treatment. Only four of 24 (17%) reported no symptom improvement after

>D-Mannose treatment.

>

>Those females who were not confirmed by culture to have bacterial UTI but

>had UTI-associated symptoms were classified into a painful-bladder-syndrome

>(PBS) group. Of the 18 PBS females who were treated daily with two scoops of

>D-Mannose, 17 (94%) reported symptom improvement, the lone exception being a

>subject unable to be contacted, but also not returning for treatment. Eighty

>percent became totally symptom free.

>

>Of the 18 male subjects, 10 were confirmed by culture to have a UTI. Seven

>had neurogenic bladders from spinal cord injuries, three of whom were on

>intermittent catheterization and four had indwelling supra-pubic tubes.

>

>Two men had been incapacitated with recurrent sepsis, retention, and

>obstructive uropathy. Both men underwent insertion of supra pubic tubes.

>Once released from the hospital, both were placed on a D-Mannose daily

>regimen. Improvement was suggested by their ability to avoid additional

>hospitalization.

>

>In the group diagnosed with E. coli-related UTI and treated with D-Mannose,

>significant improvement was reported. Due to the composition of the male

>group, few responded as dramatically as females.

>

>FINDINGS:

>

>Consistent with existing literature, about 50% of those reporting UTI

>symptoms were actually confirmed by culture to possess bacterial infection.

>The therapeutic use of D-Mannose on acute UTI¹s in this study was effective

>in eliminating or ameliorating symptoms.

>

>In addition, 80% of the painful-bladder-syndrome group became symptom free

>using D-Mannose.

>

>Over the six-month study, three females with different issues showed

>especially noteworthy responses to D-Mannose. The first was a 50-year old

>female with neurogenic bladder and incontinence suffering from a monthly

>UTI. Endoscopically, her bladder revealed numerous areas compatible with

>recurrent UTI¹s. After three months of D-Mannose, her urine was sterile, and

>her bladder mucosa returned to normal. The second woman complained about

>bladder pain for which she had received numerous, unsuccessful therapies.

>After one week of D-Mannose, her pain ceased. The third woman presented an

>E. coli infection and pronounced structural findings in her bladder called

>Cystitis Cystica, all of which disappeared after three months on D-Mannose.

>

>In conclusion, D-Mannose appears to effectively treat simple, uncomplicated

>UTI's.

>

>

>

>

>

>Opinions expressed are NOT meant to take the place of advice given by

>licensed health care professionals. Consult your physician or licensed

>health care professional before commencing any medical treatment.

>

> " Do not let either the medical authorities or the politicians mislead you.

>Find out what the facts are, and make your own decisions about how to live

>a happy life and how to work for a better world. " - Linus ing,

>two-time Nobel Prize Winner (1954, Chemistry; 1963, Peace)

>

>See our photos website! Enter " implants " for access at this link:

><http://.shutterfly.com/action/>http://.shutterfly.co\

m/action/

>

>

[Guest guest]

I take it too for infections and for IC pain.

Kenda

> I know women who swear by medical grade aloe for urinary tract infections.

>

> Lynda

>

> At 02:28 PM 12/31/2005, you wrote:

>> Hi,

>>

>> I know a few of you suffer from IC or urinary tract infections so I thought

>> I would pass along some information regarding D-Mannose, a supplement Dr.

>> Leu has prescribed for me for UTIs and IC pain. It has worked very well for

>> me almost immediately. Dr. Mercola even recommends and sells D-Mannose.

>>

>> Kenda

>>

>>

>> D-MANNOSE & URINARY TRACT INFECTIONS (Including SCI)

>> Abstracted and Edited from a Report Submitted to Progressive Laboratories by

>> Blue, M.D., Urologist (Norman, OK)

>>

>>

>>

>> See D-Mannose & UTI overview article

>>

>> INTRODUCTION:

>>

>> D-Mannose is a natural occurring simple sugar that appears to be a safe,

>> practical alternative for the treatment of urinary tract infections (UTI¹s).

>> D-Mannose is absorbed eight times slower than glucose, and when ingested, is

>> not converted to glycogen or stored in the liver, but rather goes directly

>> to the blood stream from the upper GI tract. Hence, D-Mannose is mostly

>> filtered through the kidneys and routed to the bladder.

>>

>> The bladder lining is comprised of polysaccharide molecules. Finger-like

>> projections on the cell surface of E. coli bacteria adhere to these

>> molecules, initiating an infection. In the presence of D-Mannose, E. coli

>> preferentially attach to D-Mannose molecules forming a complex which is

>> expelled with the next voiding.

>>

>> D-Mannose probably works 80-90% of the time because the bacteria disabled by

>> Mannose causes 80-90% of UTI¹s. Whereas antibiotic treatment radically

>> changes GI bacterial populations required for good health, potentially

>> causing fungal or gastrointestinal infections, D-Mannose removes ³bad²

>> bacteria by attachment and voiding.

>>

>> SUBJECTS:

>>

>> Study subjects were Dr. Blue¹s long-term patients, who had a history

>> of reoccurring UTI¹s. Subjects included 42 females (12-83 years old) and 18

>> males (25-71 years old). After urine culture to determine specific bacterial

>> cause, if any, subjects were started on a D-Mannose daily regimen.

>>

>> RESULTS:

>>

>> Of the 42 female subjects, 24 were confirmed by culture to have a UTI. In 19

>> cases (~80%), E. coli was the diagnosed cause, in four, Klebsiella, and in

>> one, mixed bacteria.

>>

>> In the confirmed culture group, two scoops of D-Mannose daily were given for

>> one week. Of the 12 (50%) who returned for follow-up cultures, eight were

>> negative. Patients indicated that the symptoms had disappeared.

>>

>> Statistically, 17 of the 24 (71%) females in the confirmed-culture,

>> D-mannose-treated group reported symptom improvement. Although three of the

>> 24 (12.5%) were unable to be contacted, they did not return for additional

>> treatment. Only four of 24 (17%) reported no symptom improvement after

>> D-Mannose treatment.

>>

>> Those females who were not confirmed by culture to have bacterial UTI but

>> had UTI-associated symptoms were classified into a painful-bladder-syndrome

>> (PBS) group. Of the 18 PBS females who were treated daily with two scoops of

>> D-Mannose, 17 (94%) reported symptom improvement, the lone exception being a

>> subject unable to be contacted, but also not returning for treatment. Eighty

>> percent became totally symptom free.

>>

>> Of the 18 male subjects, 10 were confirmed by culture to have a UTI. Seven

>> had neurogenic bladders from spinal cord injuries, three of whom were on

>> intermittent catheterization and four had indwelling supra-pubic tubes.

>>

>> Two men had been incapacitated with recurrent sepsis, retention, and

>> obstructive uropathy. Both men underwent insertion of supra pubic tubes.

>> Once released from the hospital, both were placed on a D-Mannose daily

>> regimen. Improvement was suggested by their ability to avoid additional

>> hospitalization.

>>

>> In the group diagnosed with E. coli-related UTI and treated with D-Mannose,

>> significant improvement was reported. Due to the composition of the male

>> group, few responded as dramatically as females.

>>

>> FINDINGS:

>>

>> Consistent with existing literature, about 50% of those reporting UTI

>> symptoms were actually confirmed by culture to possess bacterial infection.

>> The therapeutic use of D-Mannose on acute UTI¹s in this study was effective

>> in eliminating or ameliorating symptoms.

>>

>> In addition, 80% of the painful-bladder-syndrome group became symptom free

>> using D-Mannose.

>>

>> Over the six-month study, three females with different issues showed

>> especially noteworthy responses to D-Mannose. The first was a 50-year old

>> female with neurogenic bladder and incontinence suffering from a monthly

>> UTI. Endoscopically, her bladder revealed numerous areas compatible with

>> recurrent UTI¹s. After three months of D-Mannose, her urine was sterile, and

>> her bladder mucosa returned to normal. The second woman complained about

>> bladder pain for which she had received numerous, unsuccessful therapies.

>> After one week of D-Mannose, her pain ceased. The third woman presented an

>> E. coli infection and pronounced structural findings in her bladder called

>> Cystitis Cystica, all of which disappeared after three months on D-Mannose.

>>

>> In conclusion, D-Mannose appears to effectively treat simple, uncomplicated

>> UTI's.

>>

>>

>>

>>

>>

>> Opinions expressed are NOT meant to take the place of advice given by

>> licensed health care professionals. Consult your physician or licensed

>> health care professional before commencing any medical treatment.

>>

>> " Do not let either the medical authorities or the politicians mislead you.

>> Find out what the facts are, and make your own decisions about how to live

>> a happy life and how to work for a better world. " - Linus ing,

>> two-time Nobel Prize Winner (1954, Chemistry; 1963, Peace)

>>

>> See our photos website! Enter " implants " for access at this link:

>> <http://.shutterfly.com/action/>http://.shutterfly.

>> com/action/

>>

>>